final action
on 25 Apr 2024
Last Applicant/ Owned by
4 Maguire Road
Lexington
US
02421
Serial Number
97761200 filed on 19th Jan 2023
Registration Number
N/A
Correspondent Address
Christina M. Licursi, Esq.WOL GREENIEL & SACKS, P.C.
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
Pharmaceuticals comprised of engineered cells for the treatment of cancer, infectious diseases, and viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, renal, pulmonary, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric, immune system, inflammatory, and autoimmune related diseases and disorders
Pharmaceuticals comprised of engineered cells for the treatment of cancer, infectious diseases, and viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, renal, pulmonary, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric, immune system, inflammatory, and autoimmune related diseases and disorders
No 97761200
No Service/Collective Mark
No K07132000003
No
No
No
No
No
No
No
No
| Status Date | Action Taken |
|---|---|
| 25th Apr 2024 | TEAS/EMAIL CORRESPONENCE ENTERE |
| 24th Apr 2024 | TEAS RESPONSE TO OICE ACTION RECEIVE |
| 24th Apr 2024 | CORRESPONENCE RECEIVE IN LAW OICE |
| 29th Jan 2024 | NOTIICATION O NON-INAL ACTION E-MAILE |
| 29th Jan 2024 | NON-INAL ACTION E-MAILE |
| 29th Jan 2024 | NON-INAL ACTION WRITTEN |
| 19th Dec 2023 | TEAS/EMAIL CORRESPONENCE ENTERE |
| 19th Dec 2023 | CORRESPONENCE RECEIVE IN LAW OICE |
| 19th Dec 2023 | TEAS RESPONSE TO OICE ACTION RECEIVE |
| 18th Oct 2023 | NOTIICATION O NON-INAL ACTION E-MAILE |
